Comparison of Childhood Hepatic Malignancies in a Hepatitis B Hyper-endemic Area

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2005 Sep 9

PMID 16149134

Citations 4

Authors

Jeng-Chang Chen

Ming-Ling Chang

Jer-Nan Lin

Hong-Shiee Lai

Chiu-Chiang Chen

Wei-Jao Chen

Wen-Tsung Hung

Affiliations

Soon will be listed here.

Abstract

Aim: To examine the differences of clinical behaviors between hepatocellular carcinomas (HCC) and hepatoblastomas (HB) in children.

Methods: From 1979 to 1997, we collected 73 HCC and 54 HB from two major medical centers in Taiwan. Demog-raphic, laboratory and radiological data, and survival curves were statistically compared.

Results: HCC clinically differed from HB in mean age (10.6 vs 2.5 years; P<0.001), status of hepatitis B infection (56/56 vs 4/35, P<0.001) and accompanying liver cirrhosis (26/40 vs 0/30, P<0.001), portal vein thrombi (22/56 vs 5/38, P = 0.006) and para-aortic lymphadenopathy (10/56 vs 1/38, P = 0.026). Due to a higher recurrence rate (7/12 vs 2/13, P = 0.041), stage I HCC compared poorly in survivals with stage I HB (P = 0.0183). Chemotherapy could only benefit HB as evidenced by 66.7% of resectability conversion and improve survivals for advanced HB, even with unsuccessful conversion. The survival difference between stage I HB and advanced HB with delayed complete resection was of borderline insignificance (P = 0.0507).

Conclusion: HCC and HB were preliminarily distinguishable by some clinical clues. Delayed resection after chemotherapy was only possible for HB. However, further studies are needed to strengthen our observation that appropriate reliance upon chemotherapy to subsequently resect advanced HB could achieve the comparable survival to that of stage I HB.

Citing Articles

Cohort study of familial viral hepatitis and risks of paediatric cancers.

Heck J, Wu C, Huang X, Chew K, Tong M, Federman N Int J Epidemiol. 2021; 51(2):448-457.

PMID: 34966942 PMC: 9308392. DOI: 10.1093/ije/dyab262.

A Clinicopathological Study of Paediatric Liver Tumours in a Tertiary Care Hospital.

Muthuvel E, Chander V, Srinivasan C J Clin Diagn Res. 2017; 11(3):EC50-EC53.

PMID: 28511396 PMC: 5427322. DOI: 10.7860/JCDR/2017/24223.9592.

[4. Austrian consensus-statement for diagnosis and therapy of hepatitis B 2009].

Peck-Radosavljevic M, Deutsch J, Ferenci P, Graziadei I, Hofer H, Holzmann H Wien Klin Wochenschr. 2010; 122(9-10):280-302.

PMID: 20443069 DOI: 10.1007/s00508-009-1298-0.

Increased childhood liver cancer mortality and arsenic in drinking water in northern Chile.

Liaw J, Marshall G, Yuan Y, Ferreccio C, Steinmaus C, Smith A Cancer Epidemiol Biomarkers Prev. 2008; 17(8):1982-7.

PMID: 18708388 PMC: 2694756. DOI: 10.1158/1055-9965.EPI-07-2816.

References

Chen W, Lee J, Hung W . Primary malignant tumor of liver in infants and children in Taiwan. J Pediatr Surg. 1988; 23(5):457-61. DOI: 10.1016/s0022-3468(88)80448-2. View

Lee P, Lin W, Tsang Y, Hu R, Sheu J, Lai M . Clinical management of recurrent hepatocellular carcinoma. Ann Surg. 1995; 222(5):670-6. PMC: 1234995. DOI: 10.1097/00000658-199511000-00010. View

Hsu H, Wu T, Wu M, Sheu J, Lee C, Chen D . Tumor invasiveness and prognosis in resected hepatocellular carcinoma. Clinical and pathogenetic implications. Cancer. 1988; 61(10):2095-9. DOI: 10.1002/1097-0142(19880515)61:10<2095::aid-cncr2820611027>3.0.co;2-h. View

Sakairi T, Kobayashi K, Goto K, Okada M, Kusakabe M, Tsuchiya T . Greater expression of transforming growth factor alpha and proliferating cell nuclear antigen staining in mouse hepatoblastomas than hepatocellular carcinomas induced by a diethylnitrosamine-sodium phenobarbital regimen. Toxicol Pathol. 2001; 29(4):479-82. DOI: 10.1080/01926230152499962. View

Tong M, Reikes A, Co R . Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med. 1995; 332(22):1463-6. DOI: 10.1056/NEJM199506013322202. View

Chen J, Chen C, Chen W, Lai H, Hung W, Lee P . Hepatocellular carcinoma in children: clinical review and comparison with adult cases. J Pediatr Surg. 1998; 33(9):1350-4. DOI: 10.1016/s0022-3468(98)90005-7. View

King D, Ortega J, Campbell J, Haas J, Ablin A, Lloyd D . The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapy. J Pediatr Surg. 1991; 26(9):1074-80; discussion 1080-1. DOI: 10.1016/0022-3468(91)90677-l. View

. Hepatitis C virus infection. American Academy of Pediatrics. Committee on Infectious Diseases. Pediatrics. 1998; 101(3 Pt 1):481-5. View

Stocker J . An approach to handling pediatric liver tumors. Am J Clin Pathol. 1998; 109(4 Suppl 1):S67-72. View

10.

von Schweinitz D, Burger D, Mildenberger H . Is laparatomy the first step in treatment of childhood liver tumors?--The experience from the German Cooperative Pediatric Liver Tumor Study HB-89. Eur J Pediatr Surg. 1994; 4(2):82-6. DOI: 10.1055/s-2008-1066073. View

11.

Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y . Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology. 1990; 12(4 Pt 1):671-5. DOI: 10.1002/hep.1840120409. View

12.

Tagge E, Tagge D, Reyes J, Tzakis A, Iwatsuki S, Starzl T . Resection, including transplantation, for hepatoblastoma and hepatocellular carcinoma: impact on survival. J Pediatr Surg. 1992; 27(3):292-6; discussion 297. PMC: 2977957. DOI: 10.1016/0022-3468(92)90849-3. View

13.

Kuo G, Choo Q, Alter H, Gitnick G, Redeker A, Purcell R . An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989; 244(4902):362-4. DOI: 10.1126/science.2496467. View

14.

Pazdur R, Bready B, Cangir A . Pediatric hepatic tumors: clinical trials conducted in the United States. J Surg Oncol Suppl. 1993; 3:127-30. DOI: 10.1002/jso.2930530534. View

15.

Ortega J, Krailo M, Haas J, King D, Ablin A, Quinn J . Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group. J Clin Oncol. 1991; 9(12):2167-76. DOI: 10.1200/JCO.1991.9.12.2167. View

16.

Seo T, Ando H, Watanabe Y, Harada T, Ito F, Kaneko K . Treatment of hepatoblastoma: less extensive hepatectomy after effective preoperative chemotherapy with cisplatin and adriamycin. Surgery. 1998; 123(4):407-14. View

17.

WEINBERG A, Finegold M . Primary hepatic tumors of childhood. Hum Pathol. 1983; 14(6):512-37. DOI: 10.1016/s0046-8177(83)80005-7. View

18.

Pugh R, Murray-Lyon I, Dawson J, Pietroni M, Williams R . Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973; 60(8):646-9. DOI: 10.1002/bjs.1800600817. View

19.

Chang M, Chen C, Lai M, Hsu H, Wu T, Kong M . Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med. 1997; 336(26):1855-9. DOI: 10.1056/NEJM199706263362602. View

20.

Randolph J, Altman R, Arensman R, Matlak M, LEIKIN S . Liver resection in children with hepatic neoplasms. Ann Surg. 1978; 187(6):599-605. PMC: 1396458. DOI: 10.1097/00000658-197806000-00003. View